Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$1,078.63 USD
+14.44 (1.36%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $1,077.98 -0.65 (-0.06%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: BMO |
6/2024 | $10.55 | 0.59% |
Earnings Summary
For their last quarter, Regeneron Pharmaceuticals (REGN) reported earnings of $9.55 per share, missing the Zacks Consensus Estimate of $10.20 per share. This reflects a negative earnings surprise of 6.37%. Look out for REGN's next earnings release on August 01, 2024. For the next earning release, we expect the company to report earnings of $10.55 per share, reflecting a year-over-year increase of 3.03%.
Earnings History
Price & Consensus
Zacks News for REGN
Sanofi (SNY) Q2 Earnings Beat, Sales Miss, 2024 View Raised
REGN: What are Zacks experts saying now?
Zacks Private Portfolio Services